Advisor
ekwithree GmbH
Dr. Thomas Dobmeyer is a physician, researcher, and entrepreneur currently serving as an Advisor at ekwithree GmbH, a prominent growth investment firm specializing in tech-enabled B2B professional service providers, with a particular focus on the lifescience and healthcare sectors. In his capacity, Thomas spearheads organizational success for ekwithree and its diverse portfolio companies.
With over two decades of profound experience in the pharmaceutical and medical device industries, Thomas has held pivotal positions at PharmaLex GmbH, where he co-founded and led the transformation of a start-up consulting boutique into a globally renowned unicorn enterprise operating across 30 countries with a workforce of 3,000 employees. His strategic acumen was instrumental in shaping and executing the company's business strategies, overseeing the formation of executive teams, offering strategic counsel to shareholders, and ensuring the implementation of robust business plans to achieve organizational objectives. Under his leadership, PharmaLex completed nearly 40 mergers & acquisitions, significantly expanding its global footprint and business model.
Previously, Thomas served as the Medical Affairs Manager International at Biogen International in Nanterre, France, showcasing his versatile expertise in the international arena.
Thomas's academic journey includes a Doctoral thesis at the University of Mainz, Germany, and postgraduate studies in Clinical Evaluation at the University of Marburg, Germany. He also held positions as the Head of Research Group at the University Hospital Frankfurt, Germany, and the Paul-Ehrlich-Institute, Langen, Germany, contributing significantly to various fields including haematology, oncology, rheumatology, infectiology, and clinical immunology.
Disclosure information not submitted.
Monday, May 6, 2024
08:30 – 16:00 CEST